Laurus Labs acquires 26.62% stake in ImmunoACT for Rs 46 crore
newsdepo.com
Additionally, Laurus Labs#39; senior management will also invest in ImmunoACT for a 5.64 percent stake for approximately Rs 9.75 crore at the same price and terms, the company said in a BSE filingLaurus Labs acquires 26.62% stake in ImmunoACT for Rs 46 crore
Additionally, Laurus Labs#39; senior management will also invest in ImmunoACT for a 5.64 percent stake for approximately Rs 9.75 crore at the same price and terms, the company said in a BSE filing Read more